In last trading session, Quince Therapeutics Inc (NASDAQ:QNCX) saw 92109.0 shares changing hands with its beta currently measuring 0.73. Company’s recent per share price level of $2.04 trading at $0.02 or 0.99% at ring of the bell on the day assigns it a market valuation of $89.76M. That closing price of QNCX’s stock is at a discount of -20.1% from its 52-week high price of $2.45 and is indicating a premium of 75.0% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.45 million shares which gives us an average trading volume of 527.37K if we extend that period to 3-months.
Quince Therapeutics Inc (NASDAQ:QNCX) trade information
Upright in the green during last session for gaining 0.99%, in the last five days QNCX remained trading in the green while hitting it’s week-highest on Friday, 11/22/24 when the stock touched $2.04 price level, adding 16.73% to its value on the day. Quince Therapeutics Inc’s shares saw a change of 94.29% in year-to-date performance and have moved 10.87% in past 5-day. Quince Therapeutics Inc (NASDAQ:QNCX) showed a performance of 72.88% in past 30-days. Number of shares sold short was 2.35 million shares which calculate 2.27 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -12.64% during past 5 years.
Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders
Insiders are in possession of 13.74% of company’s total shares while institution are holding 25.53 percent of that, with stock having share float percentage of 29.60%. Investors also watch the number of corporate investors in a company very closely, which is 25.53% institutions for Quince Therapeutics Inc that are currently holding shares of the company.
